Looking for tighter spreads, rising issuance of floating-rate agency CMBS
admin | October 2, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.
Fannie Mae has recently issued its first DUS pools with underlying SOFR-indexed multifamily loans, in line with the schedule for transitioning from LIBOR to SOFR across its platform. The launch stands to bring in an important set of buyers back into the market, tightening spreads in the process and raising issuance of floating-rate CMBS.
The buyers of the new SOFR-indexed DUS ARM pools reportedly included some of the Federal Home Loan Banks, a group that began stepping back from all LIBOR markets in 2018 and 2019. The Federal Housing Finance Agency in 2019 formally instructed the FHLBanks to stop investing in LIBOR-indexed assets that matured after 2021, the scheduled expiration for LIBOR. The FHLBanks stopped investing not only in LIBOR-indexed securities but also in securities with underlying LIBOR-indexed loans. The new SOFR-indexed DUS backed by SOFR-indexed loans puts the FHLBanks back in play.
Fixed-rate DUS issuance over the last 18 months has been averaging $5.3 billion a month with DUS ARM issuance of $400 million. Historically, DUS ARM issuance averaged more than $1 billion monthly from 2015 to 2017, but issuance began to decline in early 2018 and has been fairly low since mid-2019.
Fannie Mae DUS issuance (monthly)
Source: Fannie Mae, Amherst Pierpont Securities
Although some of the decline in DUS ARM issuance is likely due to the attractiveness of low fixed rates, it also probable that many multifamily borrowers did not want the headache of getting a LIBOR-based loan when the transition to SOFR was right around the corner. Now Fannie and Freddie are offering multifamily borrowers SOFR-indexed loans at origination, so there is no uncertainty or potential upheaval due to transition issues when LIBOR ceases to be published at the end of 2021. As market participants, originators and borrowers become more comfortable with SOFR, it is likely that floating-rate loans will regain some lost ground and DUS ARM issuance could increase. The FHLBanks stepping back in as DUS ARM buyers coupled with a deeper, more liquid market over time could tighten spreads.
Background on Fannie Mae Multifamily SOFR ARMs
The transition to SOFR-indexed multifamily loans at Fannie Mae is official. The GSE will no longer accept applications for LIBOR-indexed ARMs as of September 30, 2020. The complete timeline for the transition in multifamily loans and securities is shown in Table 1.
Table 1: Fannie Mae’s timeline for multifamily transition to SOFR
Source: LIBOR Transition Playbook (page 35)
Fannie Mae announced on October 1, 2020 updates to their Multifamily MBS Prospectuses for SOFR indexed products. An overview of the product conventions and changes from Fannie Mae’s LIBOR to SOFR-indexed multifamily loans is shown in Table 2.
Table 2: Product conventions for Fannie Mae MF ARMs
Source: LIBOR Transition Playbook (page 35)
There are a few providers that are now quoting prices and selling SOFR-based interest rate caps. Fannie Mae also allows borrowers to pay for embedded caps by adding a cap cost factor into the spread to the index. Details can be found in the recently updated Multifamily Selling and Servicing Guide
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Copyright © 2023 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.